asthma
Conditions
Interventions
Group 3:None. Only collect exhaled gas condensate for comparative analysis.
Group 2:Xiao'er Jiangqi Pingxiao Heji (XEJQPX) is given orally at 20 mL once for 3-6 years old and 25 mL once for 6 years old and above, 3 times a day. The course of treatment should be given for 7 co
Group 1:Weight = 20 kg, budesonide suspension 2 mL, terbutaline sulphate nebuliser 2 mL, ipratropium bromide solution 2 mL. Add to air compression pump nebulizer for nebulized inhalation for 15 min ea
Sponsors
Nanjing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
3 Years to 12 Years
Inclusion criteria
Inclusion criteria: 1. Anyone who meets the diagnostic criteria of western medicine and the syndrome criteria of external cold and internal heat syndrome of traditional Chinese medicine; 2. Age between 3 and 12 years old, regardless of gender; 3. Acute onset, according to the judgment standard, the condition is mild or moderate; 4. No treatment has been given in the past 3 days after the onset.
Exclusion criteria
Exclusion criteria: 1. Stable condition or in asthma remission; 2. Severe asthma, status asthmaticus, critically ill patients, and patients with pulmonary infection; 3. Those who are accompanied by other diseases that cause asthma or dyspnea in patients and affect the evaluation of curative effect; 4. Patients with primary diseases such as cardiovascular and cerebrovascular, liver and kidney, and hematopoietic system; 5. Those who are allergic to the ingredients of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chinese Medicine Evidence Score;Time for clinical symptoms to disappear; | — |
Secondary
| Measure | Time frame |
|---|---|
| FeNO;Exhaled breath condensate detection;Blood Eosinophil Count;Lung function indicators; | — |
Countries
China
Contacts
Public ContactZhao Xia
Affiliated Hospital of Nanjing University of Chinese Medicine
Outcome results
None listed